Our Mission
At BioComp, we pride ourselves on the company we keep. We look for and work with companies with a strategic fit. Together, we strive to create a mutually beneficial partnership that results in high-quality generic alternatives.
| Product | Hyophen | Phosphasal | Ustell Capsules |
|---|---|---|---|
| NDC | 0076-0901-01 | 0076-0902-01 | 0076-0903-01 |
Form |
Tablets | Tablets | Capsules |
| Therapeutic Rating |
NR* | NR* | NR* |
| Therapeutic Alternative To: |
Prosed®-DS | Utira®-C | UTA Caps |
| Size | 100 | 100 | 100 |
| Bottle Type | HDPE | HDPE | HDPE |
| Therapeutic Class |
Urinary Analgesic | Urinary Analgesic | Urinary Analgesic |
| Product Description |
Round, Blue | Oval, Blue | Blue on Blue |
| Imprint | SAT / 901 | SAT / 902 | S903 |
| Prescribing Insert |
Hyophen.pdf | Phosphasal.pdf | Ustell.pdf |
* The FDA has not required that "NR" (not rated) products be approved or rated for therapeutic equivalence. There is no claim of this product(s) to other brand(s) unless explicitly noted. Even when a product is labeled as containing the same active ingredients, they may be subject to different potency and dissolution specifications and may contain different inactive ingredients. The substitution of prescription pharmaceuticals is governed by state law and, where applicable, may require the approval of the prescribing physician.